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Conditional loss of IKKα
in Osterix + cells has no effect
on bone but leads to age‑related
loss of peripheral fat
Jennifer L. Davis1,5, Nitin Kumar Pokhrel1,5, Linda Cox1, Nidhi Rohatgi2, Roberta Faccio3,4 &
Deborah J. Veis1,2,4*
NF-κB has been reported to both promote and inhibit bone formation. To explore its role in
osteolineage cells, we conditionally deleted IKKα, an upstream kinase required for non-canonical
NF-κB activation, using Osterix (Osx)-Cre. Surprisingly, we found no effect on either cancellous or
cortical bone, even following mechanical loading. However, we noted that IKKα conditional knockout
(cKO) mice began to lose body weight after 6 months of age with severe reductions in fat mass and
lower adipocyte size in geriatric animals. qPCR analysis of adipogenic markers in fat pads of cKO
mice indicated no difference in early differentiation, but instead markedly lower leptin with age. We
challenged young mice with a high fat diet finding that cKO mice gained less weight and showed
improved glucose metabolism. Low levels of recombination at the IKKα locus were detected in fat pads
isolated from old cKO mice. To determine whether recombination occurs in adipocytes, we examined
fat pads in Osx-Cre;TdT reporter mice; these showed increasing Osx-Cre-mediated expression in
peripheral adipocytes from 6 weeks to 18 months. Since Osx-Cre drives recombination in peripheral
adipocytes with age, we conclude that fat loss in cKO mice is most likely caused by progressive deficits
of IKKα in adipocytes.
Although NF-κB is primarily considered key to acute inflammatory responses, this is not universally true,
particularly for the alternative or non-canonical pathway. Unlike the canonical pathway, which is activated in
minutes and generally inactivated within hours, alternative NF-κB is induced over many hours and typically
persists for days. NIK functions as a central signaling component in this pathway, orchestrating signals from
multiple stimuli and activating the downstream kinase IKKα. This triggers phosphorylation of p100 and its partial processing, subsequently leading to persistent activation of the p52/RelB transcriptional c omplex1. Besides
participating in inflammatory responses due to its activation in immune cells, alternative NF-κB is involved
developmentally in lymph node organogenesis, via the s troma2–4, and plays a cell-extrinsic role in m
 yelopoiesis5.
Expression of NIK in intestinal epithelial cells controls specialized antigen-presenting cells in the gut6. Outside
of its effects on the immune system, alternative NF-κB has been shown to control pathologic angiogenesis via
direct actions in endothelial cells7. Upregulation of NIK in skeletal muscle occurs in patients with metabolic
syndrome and decreases with weight loss after gastric bypass8. Alternative NF-κB also plays a role in metabolism
via direct actions in pancreatic beta cells and h
 epatocytes9. Thus, there is ample evidence that the alternative
NF-κB pathway is important in a variety of cell types and physiologic contexts.
Bone is a dynamic organ, maintained by the coordinated actions of osteoblasts, which produce bone matrix,
osteoclasts, which degrade bone, and osteocytes, which act as mechanosensors directing osteoblast and osteoclast activities. Osteocytes differentiate from osteoblasts, and together these cell types comprise the osteolineage. Few studies, all employing global knockout models, have directly addressed the role of alternative NF-κB
in osteoblasts10–12. These displayed complex skeletal phenotypes, largely pointing to positive effects on bone
mass with pathway inhibition. However, we recently explored the role of alternative NF-κB in bone using a
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Figure 1.  IKKα cKO mice have similar basal bone mass compared to controls. (a) Cancellous bone volume
fraction (BV/TV) or (b) Cortical thickness (Ct.Th) of tibiae at 6 wks (n = 12), 12 wks (n = 11–13), 6 mo (n = 11),
12 mo (n = 11) by in vivo microCT. (c) Whole body bone mineral density by dual-energy x-ray absorptiometry
(DXA) for 18–20 mo mice (n = 11). Data are represented as mean ± SD. CON = black circles, cKO = red triangles,
all male mice. Non-significant between genotypes at each age by student’s, unpaired, two-tailed t-test.
constitutively active NIK allele (NT3) lacking a negative regulatory domain, expressed in the osteolineage, finding
increased bone mass13. In contrast, the effect of alternative NF-κB signaling in the osteoclast is well established.
We and others have previously shown that NIK, IKKα, and RelB support osteoclastogenesis, particularly during
pathological osteolysis12,14–20. Due to these direct effects of alternative NF-κB on osteoclasts and physiologic coupling between osteoclasts and osteoblasts, the cell autonomous role of this pathway in osteoblasts remains unclear.
To better understand the role of alternative NF-κB in bone formation, we set out to conditionally inhibit it in
osteoblasts. As in the previous study with activated NIK, we chose to target early osteoblasts for modulation of
alternative NF-κB throughout the lifespan of osteoblasts and osteocytes. The transcription factor Osterix, also
known as Sp7, is upregulated as mesenchymal stromal cells become committed to the osteoblast lineage, and in
adult mice, its expression in the skeleton is largely confined to osteoblasts and most osteocytes21,22. Therefore,
the Osterix promoter has been widely used to drive Cre expression in many studies of bone23,24. At the initiation
of this study, mice with a conditional allele for deletion of NIK were not yet available, so we employed IKKαfl/fl
mice, ablating the second kinase in the alternative NF-κB pathway.

Results

Conditional deletion of IKKα in the osteoblast lineage does not alter bone mass. We mated
IKKαfl/fl and Osx-Cre mice to generate Osx-Cre;IKKαfl/fl (cKO) and Cre-negative (CON) littermates. Dams were
kept on doxycycline throughout pregnancy and until pups were weaned to prevent early Cre expression that can
impact skeletal growth. Activation of Cre and excision of the floxed IKKα allele were assessed in bone marrowderived mesenchymal stromal cell cultures (BMSCs) under osteogenic conditions and in flushed, crushed bones
from cKO and CON littermates. Cre expression was undetectable in unstimulated BMSCs and rose during osteogenesis (Fig S1a). Interestingly, however, recombination of the IKKα allele was robust, even prior to addition of
osteogenic media (Fig S1b). Importantly, Cre expression and recombination did not occur in CON osteoblasts or
bones but were readily detected in cKO samples (Fig S1b–d). We next assessed the effect of IKKα deficiency on
osteogenesis in vitro and found a modest increase in mineralization as well as expression of osteoblast markers
(Fig S2).
We used in vivo microCT to screen for bone effects in male mice at multiple ages and found no differences in
cortical or cancellous parameters in the tibia at any time (Fig. 1a, b, Figs S3–S6). Aged males were also screened
by DXA, but again no differences in bone mass were seen (Fig. 1c). In females, ex vivo microCT at 16 weeks of
age also failed to detect bone changes after IKKα deletion (Fig S7). To determine if an anabolic condition would
elicit a bone-specific role for IKKα, we applied unilateral tibial compression for 2 weeks in skeletally mature,
16 week old male mice. However, again, we saw no differences by genotype (Fig. 2). We therefore concluded that
IKKα plays little or no role in osteogenesis in basal or mechanical loading conditions.
Aging IKKα cKO mice lose fat, associated with improved glucose metabolism. As we aged

mice to examine their bone phenotype, we noted that the cKO mice appeared smaller. Indeed, analysis of body
weights showed not only lower weights for the cKO cohorts overall at both 12 and 18 months, but also a 13%
decrease in weight in the same animals between 6 and 12 months of age, compared to a 9% increase over the
same period in CON (Fig. 3a, b). EchoMRI was then used to quantitate fat and lean mass. cKO mice displayed
distinctly lower fat mass at 12 and 18 months (47% and 62% respectively), with a more modest, but still statistically significant, decrease in lean mass (Fig. 3c, d). Post mortem, both gonadal and inguinal fat pads were smaller
in cKO than CON mice (Fig. 3e, f).
Because reductions in fat are often accompanied by changes in glucose metabolism, we challenged mice with
glucose tolerance testing (GTT) after a 6 h fast. At 7–9 mo of age, the response to glucose challenge was nearly
identical (Fig. 4a). By middle-age (13–15 mo), cKO mice showed a mild but significant decrease in peak blood
glucose levels (Fig. 4b). Old (18–20 mo) cKO animals displayed a trend towards lower peak glucose (Fig. 4c),
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Figure 2.  IKKα cKO mice have a similar response to anabolic loading compared to control. Anabolic response
to unilateral axial tibial compression was assessed by dynamic histomorphometry, measuring parameters along
the periosteum (Ps) after 2 wks. (a) Bone formation rate per bone surface (Ps.BFR/BS), (b) Mineralizing surface
per bone surface (Ps.MS/BS), and (c) Mineral apposition rate (Ps.MAR). CON = black, cKO = red, all male mice.
Right tibiae were loaded (Load, triangles) and left tibiae served as non-loaded (NL, circles) controls. Results
are presented as mean ± SD. n = 12 per genotype. 2-way ANOVA followed by Tukey’s multiple comparison test;
response to load within genotypes. There were no significant differences between genotypes, or interactions
between genotype and loading.
and this difference was further accentuated after an overnight fast (Fig. 4d), indicating improved glucose tolerance in aged cKO mice.

Osx‑Cre mediates increasing recombination in adipocytes with age. Based on these changes in
fat mass and glucose metabolism, we next sought to determine if the IKKα floxed locus was recombined in cKO
peripheral fat. We performed PCR to detect the deleted allele in inguinal, gonadal, renal, and brown fat pads
and observed the recombination product in multiple fat depots in cKO animals, but not CON (Fig. 5a). Fat
tissue contains many cell types besides adipocytes, including endothelium and other vascular components, as
well as hematopoietic cells such as macrophages. To examine Osx-Cre driven recombination in specific cells, we
used confocal microscopy to examine fat pads from Osx-Cre;TdTomato (TdT) reporter mice raised in the same
manner as the IKKα cKO mice. We found limited reporter expression in inguinal fat at 6 and 12 weeks of age,
with substantially increased signal at 6 and especially 18 months (Fig. 5b). The pattern of TdT coincided with
immunostaining for perilipin, demonstrating that recombination occurs in adipocytes. In contrast, we found no
co-staining of TdT with CD45 (Fig. 5c), indicating that recombination in hematopoietic cells in fat is unlikely to
be responsible for the observed low-fat phenotype. Therefore, we concluded that Osx-Cre drives recombination
in peripheral adipocytes in an age-dependent manner.
Aging IKKα cKO fat pads are smaller and show decreased leptin expression. To ascertain if there

were any phenotypic differences between CON and cKO adipocytes that might be driving the loss of peripheral
fat mass and improved glucose tolerance with age, we next measured adipocyte size and expression levels of various adipogenic markers. The average adipocyte area in gonadal fat pads from old cKO mice was substantially
smaller compared to CON (Fig. 6a). qPCR analysis of fat pads between 6 and 18mo animals indicated that the
key regulators of adipogenesis, PPARγ and C/EBPα25, were not different between genotypes with age (Fig. 6b
and Fig S8a). Although adiponectin and the lipolysis enzymes (hormone sensitive lipase and adipose triglyceride
lipase) trended modestly downward at both ages in cKO compared to CON animals, they did not reach statistical
significance (Fig S8a, b). In contrast, with loss of IKKα, expression of leptin, the satiety hormone26, is markedly
decreased in old cKO fat pads (Fig. 6c). Given the smaller size of cKO adipocytes and reduced leptin levels, we
monitored food intake to see if loss of IKKα impacted feeding habits. Indeed, middle aged cKO animals showed
increased food consumption relative to CON, and not a decrease that could drive fat loss (Fig. 6d). All together,
this data suggests that cKO animals are protected from the perturbations to adipocyte function that occur during aging.

IKKα cKO mice show a blunted response to high fat diet. To further investigate the fat phenotype
observed in aging cKO mice, we fed younger animals according to a well-established high fat diet (HFD) paradigm as an alternative metabolic stress. Mice were maintained on this diet (60%kcal/fat) beginning at 8 weeks
of age, prior to any difference in body weight between CON and cKO mice (Figs. 7a and S9a). Male cKO mice
showed blunted weight gain which did not reach statistical significance following 8 weeks of HFD, although total
fat mass was decreased by ECHO MRI (Fig S9b, c). Attenuation of weight gain in female cKO mice was significant (60% increase in CON vs 40% increase in cKO) (Fig. 7b), associated with a marked reduction in fat mass
(Fig. 7c). Total lean mass was unchanged in both sexes, compared to CON (Fig. 7d and S9d).
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Figure 3.  IKKα cKO mice have attenuated weight gain, lower total fat, and less lean mass with age. (a) Body
weights at 6 mo (n = 15–16), 12 mo (n = 28–31), 18 mo (n = 11–13). (b) Weight change (%) from 6 to 12 mo
(n = 11). EchoMRI measurement of (c) total fat mass and (d) total lean mass at 6mo (n = 6), 12mo (n = 5–9),
18mo (n = 10–11). (e) Gonadal and (f) Inguinal fat pad weights at 12 mo (n = 4–9) and 18 mo (n = 11–14). Data
are represented as mean ± SD, all male mice. CON = black, cKO = red. Student’s, unpaired, two-tailed t-test (for
b) or 2-way ANOVA followed by Sidak multiple comparisons test (cross genotype comparisons): ns – nonsignificant.

After 8–11 weeks on HFD, male cKO mice showed a trend towards better glucose tolerance, but this did not
reach statistical significance in our cohorts (Fig S9e). Glucose tolerance in females after 8–11 weeks similarly
trended better in cKO mice (Fig. 8a, b). Insulin tolerance was not significantly different in either sex at this point,
although female cKO showed a slight trend towards better tolerance (Figs. 8c, d and S9f.). We then decided to
continue HFD in a subset of females for 20–23 weeks. After this extended period, body weight continued to be
lower in cKO, and both glucose and insulin tolerance were significantly improved compared to CON (Fig. 8e–i).
Because significant changes in weight and fat mass occurred long before alterations in glucose metabolism, it is
likely that the metabolic effects are secondary to, rather than the primary drivers of, weight gain.
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Figure 4.  Older IKKα cKO mice show improved glucose tolerance. Glucose Tolerance Test (GTT) was
performed after a 6 h fast at all ages and overnight (O/N) at 18–20 mo. CON = black, cKO = red, all male mice.
Blood glucose measurements at (a) 7–9 mo (n = 7–9), (b) 13–15 mo (n = 5–6), (c) 18–20 mo (n = 4–7), and
(d) 18–20 mo after O/N fast (n = 4–7). Data are represented as mean ± SD. Repeated measures 2-way ANOVA
followed by Sidak multiple comparisons test, with p values indicated where significant.

Figure 5.  Osx-Cre mediates recombination in peripheral adipocytes. (a) PCR of genomic DNA from inguinal
fat (IF), gonadal fat (GF), renal fat (RF), and brown fat (BF), isolated from 15 mo male mice. Whole, flushed
bone was used as a positive control (POS). Intact floxed allele = 1.3 kb and recombination product = 460 bp.
*, sample lost in loading. Right panel was originally on the bottom row of the same gel as the left panel. n = 3
biological replicates. Representative immunofluorescence staining for (b) Perilipin (green) or (c) CD45 (green)
in inguinal fat from Osx-Cre;TdT reporter mice (red) at 6 wks, 12 wks, 6 mo, 18 mo, or Osx-Cre control mice at
18 mo.
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Figure 6.  Aging IKKα cKO fat pads are smaller and show decreased leptin expression. (a) (left) Representative
H&E staining of gonadal fat from 18 months old CON and cKO mice and (right) quantification of adipocyte
size. CON = black, cKO = red. (b) qPCR for PPARγ from gonadal fat in CON (n = 4–9) and cKO (n = 4–7) mice
at indicated ages. (c) qPCR for Leptin, as in (b). (d) Total food intake was measured daily over 3–4 days in
CON (n = 4–5) and cKO (n = 5–9) mice at indicated ages and normalized to bodyweight. Data represented as
mean ± SD. At least 350 adipocytes from 3 independent samples of each genotype were measured and unpaired,
two-tailed student’s t-test was performed (for a). Technical duplicates were averaged (b,c), and 2-way ANOVA
followed by Sidak multiple comparisons test was performed (b,c,d), with values indicated where significant.

Discussion

In this study, we set out to examine the role of alternative NF-κB signaling in the osteolineage by targeting a
key upstream kinase, IKKα, using Osx-Cre. Previously, we found that forced activation of this pathway using
a constitutively active allele of NIK with the same Osx-Cre driver enhanced both basal and stimulated bone
formation13. Here, male cKO mice showed no differences in bone mass up to 18 months of age, and mechanical
loading by tibial compression failed to generate any differences in bone formation. Female mice also had normal bone mass at 4 months of age. Thus, under basal and non-inflammatory loading conditions, IKKα does not
seem to have a clear role, either positive or negative, in bone formation. One limitation of our bone analysis is
that we did not follow females over time, despite our finding that global loss of alternative NF-κB components
NIK and RelB has greater effect in females. However, in those models, the differences are clear by 10 weeks of
age12. It is possible that IKKα may impact bone formation in the context of strong inflammatory stimuli such as
inflammatory arthritis models, which were not examined here.
Surprisingly, while we followed cKO mice for a potential age-dependent effect in bone, we were struck by
overt differences in weight that widened with age. Further investigation revealed that this was driven primarily
by lower fat mass, which preceded changes in glucose metabolism and modest changes in lean mass. Adipocytes
in old cKO fat pads had a much smaller average area than CON. Expression of early and mature adipocyte markers was normal or trended modestly lower in cKO fat pads from both young and aged mice. In contrast, leptin
was dramatically decreased with age. Indeed, cKO animals displayed a trend towards increased food intake that
became significant by middle age, when weights were distinctly lower. Thus, decreased appetite is unlikely to be
driving the loss of fat. Using HFD as a metabolic stress in young cKO mice, we also observed less fat accumulation. However, additional studies are necessary to determine if this is driven by similar mechanisms as in aging.
Given the striking loss of fat in aging cKO mice in the absence of any changes in bone, we considered the
possibility that recombination outside of bone was responsible for the phenotype. PCR of genomic DNA from
peripheral fat depots in middle aged mice showed recombination of the IKKα allele, albeit less than in bone.
Examination of inguinal fat pads from Osx-Cre;TdT reporter mice showed robust TdT expression only in adipocytes from aged mice. Despite identification of TdT in several subsets of CD45 + cells in a previous study
using the same line of reporter m
 ice27, we did not identify any such cells in the inguinal fat sections at any age.
Strengthening our assertion that Osx-Cre drives loss of IKKα in adipocytes, expression of endogenous Osx has
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Figure 7.  IKKα cKO mice show blunted weight and fat gain after HFD. Body weights (BW), (a) Initial or
(b) after HFD for 8 wks. (c) EchoMRI of total fat mass or (d) total lean mass after 8wks on HFD. CON = blue,
cKO = green. Data are represented as mean ± SD. Female mice (initial BW, n = 15–23; HFD BW, n = 12–18;
EchoMRI, n = 10–14). Repeated measures 2-way ANOVA followed by Sidak multiple comparisons test for body
weight on HFD for b and Student’s, unpaired, two-tailed t-test for a,c, and d. HFD = high fat diet.

been reported during differentiation of the preadipocytic cell line 3T3-L128. Furthermore, the Osx-Cre allele has
established recombination activity in many extraskeletal tissues including synovium29, intestinal epithelium30,31,
and kidney32, as well as in some hematopoietic stem and progenitor c ells27. In tumor bearing mice, Osterix, as
well as the Osx-Cre allele, is also expressed in a subset of cancer-associated fibroblasts with a dual fibroblast/
osteogenic signature27. Recently, we found subcutaneous sarcomas, but not bone tumors, in mice expressing a
transgene driven by Osterix-Cre33. Thus, it is possible that loss of IKKα in adipocytes themselves is responsible
for the observed fat phenotype.
Most studies of the role of NF-κB in adipocytes have focused on IKKβ, an apex kinase in the canonical pathway. Manipulation of IKKβ in adipocyte lineage cells in mouse models has complex and stage-specific effects
on fat mass, glucose homeostasis, and response to H
 FD34–37. Thus, the role of IKKβ in the adipocyte lineage is
complex, and the effects of aging have not been reported in any of these models. Data on the role of IKKα or
other components of alternative NF-κB in metabolism is even more limited, with roles described in pancreatic
islets, hepatocytes, and skeletal muscle9. In particular, HFD feeding hyperactivated alternative NF-κB in pancreatic islets resulting in β-cell failure38. While it is possible that age or HFD activates Osx-Cre in a metabolic
organ such as pancreas, we find changes in weight prior to changes in glucose metabolism, suggesting that this
is a secondary response, rather than a driver of the cKO phenotype. Future studies using an adipocyte-specific
Cre such as Adiponectin-Cre are needed to determine if there is a cell-autonomous role for IKKα in adipocytes.
In addition to the unexpected finding of a fat phenotype driven by Osx-Cre, we also did not anticipate the
strong effect of age on activation of this Cre. Previous studies utilizing this Cre driver primarily utilize mice under
6 months of age, and the few studies with mice at or beyond 1 year of age did not describe, or specifically look for,
Cre expression outside of bone39–41. Since this study was undertaken to examine the role of IKKα in bone, studies
of fat and metabolism were not initially planned. By the time the fat phenotype in aging males was discovered,
it was not practical to undertake a similar study in females. Therefore, we decided to investigate whether differences in fat could be accelerated using HFD in both sexes. Interestingly, although both male and female cKO
mice had less fat than CON after 8 weeks on the obesogenic diet, the difference in overall body weight was more
pronounced in females. Thus, like osteoclasts12, adipocytes may have differential sensitivity to the alternative
NF-κB pathway by sex. Alternatively, HFD may induce Osx-Cre expression in adipocytes, similar to aging, and
the rate of this may differ between males and females.
In sum, using an Osx-Cre driven conditional knockout approach, we found no clear role for IKKα in the
osteolineage in either basal or mechanically stimulated conditions, but rather an intriguing role for IKKα in fat
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Figure 8.  IKKα cKO mice show improved glucose metabolism after HFD. Blood glucose levels were measured
during Glucose Tolerance Tests (GTT) and Insulin Tolerance Tests (ITT), which were initiated after a 6 h fast, in
female mice. (a–d) Tests were performed after 8–11 wks on HFD (n = 6–10). (a) GTT, (b) area under the curve
(AUC) for GTT, (c) ITT, and (d) AUC for ITT. (e–i) Tests were repeated on a subset of mice after 20–23 wks
on HFD (n = 4–6). (e) body weight at time of GTT, (f) GTT, (g) AUC for GTT, (h) ITT, and (i) AUC for ITT.
CON = blue, cKO = green. Data are represented as mean ± SD. Repeated measures 2-way ANOVA followed by
Sidak multiple comparisons test for GTT and ITT or Student’s, unpaired, two-tailed t-test for body weight and
AUC.
accumulation. cKO mice were protected from age-related or HFD-induced metabolic dysfunction, and remained
lean. With increasing recognition of bone as an endocrine organ, it is tempting to conclude that phenotypes arising from conditional alleles driven by Osx-Cre are due to the osteolineage. However, our finding of an age-related
increase in Osx-Cre expression in peripheral fat indicates that expression outside of bone should be considered
when metabolic phenotypes are identified in aged animals. More comprehensive analysis of conditional mouse
models with sensitive reporters like TdT is likely to uncover other so-called off-target effects that arise with aging
in many Cre lines. Although it is not yet clear if the adipocyte is the target cell, the results shown here suggest that
inhibition of IKKα, or potentially other alternative NF-κB pathway components, may reduce fat accumulation
with age and preserve glucose metabolism.

Materials and methods

Mice. Mice were communally housed in a pathogen-free barrier facility, with controlled temperature and
12-h light/dark cycles. They had ad libitum access to fresh water and standard rodent chow (5058; Purina, St.
Louis, MO, USA) unless otherwise indicated. Protocols were approved by Institutional Animal Studies Committee at Washington University School of Medicine (ASC protocols 20170025 and 19-1059) and all methods
were performed in accordance with the relevant guidelines and regulations, including with ARRIVE guidelines.
The IKKα flox transgenic line was generated as described e lsewhere42. Osx1-GFP::Cre mice (006361; The
Jackson laboratory, ME USA) express Cre-recombinase under control of a Tet-OFF cassette23. The IKKα flox
transgenic and Osx1-GFP:Cre (Osx-Cre) parental mouse lines were maintained separately due to strain differences (C57Bl/6J and mixed C57Bl/6J and CD1, respectively). Osx-Cre;IKKαfl/fl (cKO) mice and Cre-negative
WT;IKKαfl/fl (CON) littermates were maintained on a 200 ppm doxycycline chow diet (1816332–203; Purina
Test Diet, St. Louis, MO, USA). Pups were switched to standard rodent chow at weaning (P21-P22). To generate
TdTomato (TdT) reporter mice, Osx-Cre mice were crossed with TdT mice (007909; The Jackson Laboratory, ME
USA), and pups were maintained on the same doxycycline chow until weaning (P21-P22). Age and sex-matched
animals from the same colony were used in all experiments.
Micro‑computed tomography.

The right tibia of mice was scanned by microCT in vivo (VivaCT 40,
Scanco, Brüttisellen, Switzerland) at 10.5 mm resolution (70 kVp, 114 mA, 8 W, 100 ms integration time). Cancellous bone parameters were measured at a 1 mm region distal to the end of the tibial growth plate. Cortical
measurements were made at the tibial mid-shaft (1 mm region defined 5 mm proximal to the distal tibiofibular
junction). Bone indices are reported in accordance with established standards43.
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Dual‑energy X‑ray absorptiometry (DXA). Whole body DXA scans were performed on 18 month male
CON and cKO mice using a Faxitron UltraFocus 100 machine (Faxitron, Buffalo Grove, IL, USA).
Mechanical loading and dynamic histomorphometry. Unilateral axial tibial compression (Electropulse 1000; Instron, Norwood, MA, USA) and dynamic histomorphometry (Bioquant Osteo software v18.2.6;
Bioquant Image Analysis Corp., Nashville, TN, USA) was performed on the right tibiae of 16-week-old, male
mice as previously described13. The left tibia served as the contralateral non-loaded control. Strain gauging was
performed to determine the force necessary for a 2000 microstrain deformation (9.6 N, both genotypes). In
samples where the mineral apposition rate was zero, an imputed value of 0.1 was used to allow for statistical
comparisons. All measurements were acquired in a blinded fashion and reported in accordance with published
standards43.
Genomic DNA recombination. Long bones were flushed of marrow and crushed in TRIzol (15596026;
Invitrogen, USA) using a Navy RINO lysis kit and Bullet Blender Tissue Homogenizer (Next Advance, Troy, NY,
USA). Peripheral fat depots were processed similarly to crushed bone samples. Cell cultures were rinsed 2 × with
PBS, then lysed directly in TRIzol. Genomic DNA was extracted using a back extraction buffer (4 M guanidine
thiocyanate, 50 mM sodium citrate, 1 M Tris) and alcohol precipitation. 50 ng of input gDNA per sample using
GoTaq polymerase (M7123; Promega, USA). PCR cycling conditions: 94 °C–4 min; (94 °C–30 s, 55 °C–45 s,
72 °C–1.5 min) × 30 cycles; 72 °C–10 min; 12 °C hold. Primer sequences for recombination: Forward—CTT
TGC CAT CAT CTC TCC GGT TTG TAA; Reverse—CAA TAG GAT AAT CAC TAA GCA CAG T.
High fat diet. Mice were fed a 60% kcal/fat diet (D12492; Research Diets Inc, New Brunswick, NJ, USA),
ad libitum, beginning at 8–9 weeks of age. Body weight was measured once a week. At sacrifice, peripheral fat
pads were weighed after removal of any gross contaminating tissue.
EchoMRI. Lean and fat mass was assessed by EchoMRI body composition analysis (EchoMRI LLC, Houston
TX, USA) in non-fasted mice. Each mouse was scanned twice and the average value was used for analysis.

Glucose and insulin tolerance tests.

Mice were housed on aspen bedding and administered intraperitoneally a 1 mg/g dose of dextrose or 0.75U/kg of insulin (HumulinR U-100; Eli Lily, USA) after a 6 h or overnight
fast (food only), as indicated. Tail vein blood was sampled at intervals over a 2 h period and blood glucose was
measured using a Bayer Contour meter (9556C; Bayer HealthCare, Mishawaka, IN, USA) and accompanying
test strips.

Immunostaining and fluorescence imaging. Inguinal fat was embedded in optimal cutting temperature compound (OCT; 23-730-571, Thermo Fisher Scientific, USA) and flash frozen at − 80 °C. Embedded tissues
were post fixed in 10% neutral buffered formalin and cut at 50 μm on a cryostat (Leica, Buffalo Grove, IL, USA).
For immunostaining, cut sections on glass slides were blocked in 10% goat serum in Tris- NaCl- Tween (TNT)
buffer before incubation for 24 h with primary antibodies; anti-perilipin 1 (N-terminus) guinea pig polyclonal
(LS-C665927-100,GP29; LS Bio, USA) (1:1000), anti-CD45 monoclonal antibody (30-F11)(14-051-82; Thermo
Fisher Scientific, USA) (1:200) overnight at 4 °C. After washing 3 × 5 min with TNT, secondary antibodies (Alexa
488 (A-11073; Thermo Fisher Scientific, USA) or Alexa 488 (A-48269; Thermo Fisher Scientific, USA) in TNT
buffer were applied for 1 h at room temperature. The sections were then washed 3 × 5 min in TNT buffer, before
mounting with Fluoromount-G (00-4958-02; Thermo Fisher Scientific, USA). Images were captured using Leica
DMi8 automated inverted microscope equipped with ACS APO 20x/0.60 Lens (Leica Microsystems).
Adipocyte size. Gonadal fat pads were excised and fixed in 10% neutral buffered formalin. 5 μm paraffin-embedded sections were subjected to hematoxylin and eosin staining. Standard bright field images were
acquired. Adipocyte area was measured using Image J (NIH, Version 1.53).
Quantitative real‑time PCR.

Peripheral fat pads were homogenized in TRIzol as described above. Total
RNA was extracted with chloroform:isoamyl alcohol. An equal volume of 70% ethanol was added followed by
purification with a NucleoSpin RNA II kit (740955.50; Takara Bio, USA). cDNA was reverse-transcribed using
1 μg of total RNA per manufacturer’s instructions (639549; Takara Bio, USA). PCR cycling was performed using
iTaq Universal SYBR Green Supermix (1725121; Bio-Rad, USA) on an Applied Biosystems QuantStudio 3 using
the following settings: 50 °C for 2 min, 95 °C for 10 min, and then 40 cycles of 95 °C for 15 s and 60 °C for 1 min.
Relative expression was calculated as 2− (target CT − GAPDH CT). Primer sequences are listed in Supp Table 2.

Food intake studies. Mice were acclimated to single housing and then food intake was measured daily
for 3–4 days by subtracting starting and ending normal chow pellet weights. Total food intake was averaged per
mouse and expressed normalized to body weight.
Statistical analysis. All statistics were computed using GraphPad Prism software (Version 9.2.0, Graph-

Pad Software, Inc., La Jolla, CA, USA). Values of p < 0.05 were considered significant and data are presented as
mean ± SD. For pairwise comparisons, either a student’s, unpaired, two-tailed t-test or student’s paired, twotailed t-test was used. A Welch’s correction was applied to the t-test if the F-test to compare variances was sig-
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nificantly different. For multiple group comparisons, a 2-way ANOVA followed by Tukey’s multiple comparisons
test was performed. For repeated measure group comparisons, a 2-way repeated measures ANOVA followed by
Sidak’s multiple comparisons test was performed. A mixed-effect model was used if sample sizes differed. Specific statistical tests and sample sizes are indicated in the respective figure legends.

Received: 30 November 2021; Accepted: 10 March 2022

References

1. Sun, S. C. Non-canonical NF-kappaB signaling pathway. Cell Res. 21, 71–85. https://doi.org/10.1038/cr.2010.177 (2011).
2. Benezech, C. et al. Lymphotoxin-beta receptor signaling through NF-kappaB2-RelB pathway reprograms adipocyte precursors as
lymph node stromal cells. Immunity 37, 721–734. https://doi.org/10.1016/j.immuni.2012.06.010 (2012).
3. Roozendaal, R. & Mebius, R. E. Stromal cell-immune cell interactions. Annu. Rev. Immunol. 29, 23–43. https://doi.org/10.1146/
annurev-immunol-031210-101357 (2011).
4. Weih, F. & Caamano, J. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction
pathway. Immunol. Rev. 195, 91–105. https://doi.org/10.1034/j.1600-065x.2003.00064.x (2003).
5. Briseno, C. G. et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic
mechanisms. Proc. Natl. Acad. Sci. USA 114, 3957–3962. https://doi.org/10.1073/pnas.1619863114 (2017).
6. Ramakrishnan, S. K. et al. Intestinal non-canonical NFkappaB signaling shapes the local and systemic immune response. Nat.
Commun. 10, 660. https://doi.org/10.1038/s41467-019-08581-8 (2019).
7. Noort, A. R. et al. NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.
J. Pathol. 234, 375–385. https://doi.org/10.1002/path.4403 (2014).
8. Choudhary, S. et al. NF-kappaB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin.
Endocrinology 152, 3622–3627. https://doi.org/10.1210/en.2011-1343 (2011).
9. Sun, S. C. The non-canonical NF-kappaB pathway in immunity and inflammation. Nat. Rev. Immunol. 17, 545–558. https://doi.
org/10.1038/nri.2017.52 (2017).
10. Seo, Y. et al. Accumulation of p100, a precursor of NF-kappaB2, enhances osteoblastic differentiation in vitro and bone formation
in vivo in aly/aly mice. Mol. Endocrinol. 26, 414–422. https://doi.org/10.1210/me.2011-1241 (2012).
11. Yao, Z. et al. NF-kappaB RelB negatively regulates osteoblast differentiation and bone formation. J. Bone Miner. Res. 29, 866–877.
https://doi.org/10.1002/jbmr.2108 (2014).
12. Zarei, A. et al. Manipulation of the alternative NF-kappaB pathway in mice has sexually dimorphic effects on bone. JBMR Plus 3,
14–22. https://doi.org/10.1002/jbm4.10066 (2019).
13. Davis, J. L. et al. Conditional activation of NF-kappaB inducing kinase (NIK) in the osteolineage enhances both basal and loadinginduced bone formation. J. Bone Miner. Res. 34, 2087–2100. https://doi.org/10.1002/jbmr.3819 (2019).
14. Novack, D. V. et al. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198, 771–781.
https://doi.org/10.1084/jem.20030116 (2003).
15. Vaira, S. et al. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci.
USA 105, 3897–3902. https://doi.org/10.1073/pnas.0708576105 (2008).
16. Yang, C. et al. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS ONE 5, e15383.
https://doi.org/10.1371/journal.pone.0015383 (2010).
17. Zeng, R., Faccio, R. & Novack, D. V. Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial
biogenesis via independent mechanisms. J. Bone Miner. Res. 30, 2287–2299. https://doi.org/10.1002/jbmr.2584 (2015).
18. Chaisson, M. L. et al. Osteoclast differentiation is impaired in the absence of inhibitor of κB kinaseα. J. Biol. Chem. 279, 54841–
54848 (2004).
19. Taniguchi, R. et al. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in
alymphoplasia mice by promoting NF-kappaB2 processing by IKKalpha. J. Biol. Chem. 289, 7349–7361. https://doi.org/10.1074/
jbc.M113.538314 (2014).
20. Soysa, N. S. et al. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J. Bone Miner. Res. 25, 809–818. https://doi.org/10.1359/jbmr.091030 (2010).
21. Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and
bone formation. Cell 108, 17–29. https://doi.org/10.1016/s0092-8674(01)00622-5 (2002).
22. Baek, W. Y. et al. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J. Bone Miner. Res.
24, 1055–1065. https://doi.org/10.1359/jbmr.081248 (2009).
23. Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and
maintenance of osteoblast progenitors. Development 133, 3231–3244. https://doi.org/10.1242/dev.02480 (2006).
24. Elefteriou, F. & Couasnay, G. Advantages and limitations of Cre mouse lines used in skeletal research. Methods Mol. Biol. 2230,
39–59. https://doi.org/10.1007/978-1-0716-1028-2_3 (2021).
25. Ahmad, B., Serpell, C. J., Fong, I. L. & Wong, E. H. Molecular mechanisms of adipogenesis: The anti-adipogenic Role of AMPactivated protein kinase. Front. Mol. Biosci. 7, 76. https://doi.org/10.3389/fmolb.2020.00076 (2020).
26. Pan, W. W. & Myers, M. G. Jr. Leptin and the maintenance of elevated body weight. Nat. Rev. 19, 95–105. https://doi.org/10.1038/
nrn.2017.168 (2018).
27. Ricci, B. et al. Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with protumorigenic characteristics. eLife https://doi.org/10.7554/eLife.54659 (2020).
28. Han, Y., Kim, C. Y., Cheong, H. & Lee, K. Y. Osterix represses adipogenesis by negatively regulating PPARgamma transcriptional
activity. Sci. Rep. 6, 35655. https://doi.org/10.1038/srep35655 (2016).
29. Miura, Y., Ota, S., Peterlin, M., McDevitt, G. & Kanazawa, S. A subpopulation of synovial fibroblasts leads to osteochondrogenesis
in a mouse model of chronic inflammatory rheumatoid arthritis. JBMR Plus 3, e10132. https://d
 oi.o
 rg/1 0.1 002/j bm4.1 0132 (2019).
30. Chen, J. et al. Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice. PLoS ONE 9, e85161. https://doi.
org/10.1371/journal.pone.0085161 (2014).
31. Wang, L. et al. SHP2 regulates the development of intestinal epithelium by modifying OSTERIX(+) crypt stem cell self-renewal
and proliferation. FASEB J. 35, e21106. https://doi.org/10.1096/fj.202001091R (2021).
32. Strecker, S., Fu, Y., Liu, Y. & Maye, P. Generation and characterization of Osterix-Cherry reporter mice. Genesis (New York, N.Y. :
2000) 51, 246–258. https://doi.org/10.1002/dvg.22360 (2013).
33. Davis, J. L. et al. Constitutive activation of NF-kappaB inducing kinase (NIK) in the mesenchymal lineage using Osterix (Sp7)- or
Fibroblast-specific protein 1 (S100a4)-Cre drives spontaneous soft tissue sarcoma. PLoS ONE 16, e0254426. https://doi.org/10.
1371/journal.pone.0254426 (2021).

Scientific Reports |
Vol:.(1234567890)

(2022) 12:4915 |

https://doi.org/10.1038/s41598-022-08914-6

10

www.nature.com/scientificreports/
34. Park, S. H. et al. IKKbeta is essential for adipocyte survival and adaptive adipose remodeling in obesity. Diabetes 65, 1616–1629.
https://doi.org/10.2337/db15-1156 (2016).
35. Kwon, H. et al. Adipocyte-specific IKKbeta signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine
feedback pathway. Cell Rep. 9, 1574–1583. https://doi.org/10.1016/j.celrep.2014.10.068 (2014).
36. Helsley, R. N. et al. Targeting IkappaB kinase beta in adipocyte lineage cells for treatment of obesity and metabolic dysfunctions.
Stem Cells 34, 1883–1895. https://doi.org/10.1002/stem.2358 (2016).
37. Jiao, P. et al. Constitutive activation of IKKbeta in adipose tissue prevents diet-induced obesity in mice. Endocrinology 153, 154–165.
https://doi.org/10.1210/en.2011-1346 (2012).
38. Malle, E. K. et al. Nuclear factor kappaB-inducing kinase activation as a mechanism of pancreatic beta cell failure in obesity. J.
Exp. Med. 212, 1239–1254. https://doi.org/10.1084/jem.20150218 (2015).
39. Ng, A. J. et al. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation. PLoS Genet. 11,
e1005160. https://doi.org/10.1371/journal.pgen.1005160 (2015).
40. Zannit, H. M. & Silva, M. J. Proliferation and activation of osterix-lineage cells contribute to loading-induced periosteal bone
formation in mice. JBMR Plus 3, e10227. https://doi.org/10.1002/jbm4.10227 (2019).
41. Pierce, J. L. et al. The glucocorticoid receptor in Osterix-expressing cells regulates bone mass, bone marrow adipose tissue, and
systemic metabolism in female mice during aging. J. Bone Miner. Res. https://doi.org/10.1002/jbmr.4468 (2021).
42. Liu, B. et al. IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 14, 212–225. https://doi.org/
10.1016/j.ccr.2008.07.017 (2008).
43. Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report
of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2–17. https://doi.org/10.1002/jbmr.1805
(2013).

Acknowledgements

This work was supported by National Institutes of Health Grants R01 AR052705 and P01 CA100730 (to DJV),
R01 AR070030 (to DJV and RF), R01 AR066551 (to RF), and F31 AR068853 and T32 CA113275 (to JLD).
MicroCT and histology services were provided by the Washington University Musculoskeletal Research Center’s
Structure and Strength and Histology and Morphometry Cores, supported by P30 AR074992. EchoMRI analysis
was performed in the Washington University Nutrition Obesity Research Center, supported by P30 DK056341
via a just-in-time grant. Additional support was provided by the Siteman Cancer Center Investment Program, St.
Louis, MO to RF. Funding from Shriners Hospitals for Children was provided to DJV and RF. We wish to thank
Crystal Idleburg for histological expertise, Dr. Giulia Furesi for flow cytometry, and Dr. Sangeeta Adak and Dr.
Erica Scheller for assistance with fat and metabolism experiments.

Author contributions

J.L.D.—experimental design, data acquisition, analysis, and interpretation, drafting and revision of manuscript.
N.K.P.—data acquisition and analysis, drafting and revision of manuscript. L.C. —data acquisition. N.R. —
experimental design, data interpretation. R.F. —experimental design, data interpretation. D.J.V. —experimental
design, data interpretation, drafting and revision of manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Supplementary Information The online version contains supplementary material available at https://doi.org/
10.1038/s41598-022-08914-6.
Correspondence and requests for materials should be addressed to D.J.V.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2022

Scientific Reports |

(2022) 12:4915 |

https://doi.org/10.1038/s41598-022-08914-6

11
Vol.:(0123456789)

